Israel's Health Data Grid Powers a New Era of Preventive Medicine

TEL AVIV, Israel – July 28, 2026 – In the global race to outsmart chronic disease, the most powerful tool may not be a new drug or scanner, but the invisible digital infrastructure that underpins a nation’s health. A new research collaboration between clinical intelligence firm Longevity AI and Meir Medical Center, part of Israel’s largest healthcare provider Clalit Health Services, aims to prove just that. The partnership will leverage one of the world's most comprehensive healthcare datasets to retrain and refine AI models that can predict cardiovascular disease and Type 2 diabetes, shifting the paradigm from reactive treatment to proactive, data-driven prevention.

The Digital Backbone of Proactive Health

At the heart of this initiative lies a piece of critical national infrastructure: Clalit's longitudinal healthcare dataset. With unified electronic health records spanning over two decades for nearly five million patients across 14 hospitals and 1,500 clinics, this is far more than just "big data." It is a meticulously structured digital twin of a population's health journey, a resource that provides the raw material for building a truly intelligent health network. Israel’s highly digitized healthcare system, where over 98% of records are electronic, has created the ideal proving ground for data-intensive medical innovation.

Longevity AI, a Tel Aviv and New York-based company, is building the intelligence layer atop this digital backbone. The company's platform is designed to ingest and analyze this population-scale data to identify subtle patterns and risks that are invisible to the naked eye or traditional diagnostic methods. Rather than building a new prediction model from scratch, the collaboration focuses on a more pragmatic and powerful approach: recalibrating globally recognized clinical risk models using contemporary, real-world evidence from Clalit's diverse patient population.

"With 14 hospitals, approximately 1,500 clinics, and unified electronic health records covering close to five million patients, Clalit has built one of the most comprehensive longitudinal healthcare datasets globally," said Guy Leitersdorf, Founder and CEO of Longevity AI. This creates a "unique foundation for advancing research in preventive care and chronic disease management," he added, highlighting the synergy between deep data infrastructure and advanced AI.

Recalibrating Risk in the Real World

Many of the chronic conditions that burden modern healthcare systems, like heart disease and diabetes, develop silently over years. By the time symptoms appear, the window for effective, low-cost intervention has often narrowed significantly. Existing clinical risk calculators, such as the Framingham Risk Score, have been foundational but often have limitations. Developed decades ago using data from specific, often homogeneous populations, their predictive power can wane when applied to the diverse and dynamic patient populations of today.

The joint research project directly confronts this challenge. Led by Meir Medical Center’s Professor Pnina Rotman-Pikielny and Dr. Liat Barzilay-Yoseph, alongside Longevity AI's technical team, the effort will test how these established models perform against the reality of Clalit's vast dataset.

"Many chronic conditions develop silently for years before symptoms appear, limiting opportunities for early intervention," explained Professor Rotman-Pikielny, Director of the Endocrinology Department at Meir. "Finding better ways to identify patients at elevated risk before disease progresses remains one of the most important challenges in preventive medicine."

By retraining these models with contemporary data, the AI can learn the specific nuances of the local population, accounting for demographic, environmental, and clinical factors that older models miss. This recalibration could lead to significantly more accurate and personalized risk scores, allowing clinicians to focus preventive efforts on those who will benefit most. "This research collaboration reflects our commitment to responsibly evaluating innovative tools that may support earlier risk detection and more personalized preventive care," added Dr. Barzilay-Yoseph.

From Data to Decision: The AI-Clinician Interface

Raw predictive power is useless if it doesn't integrate seamlessly into the complex environment of clinical care. A critical component of Longevity AI's strategy is its "Florence" platform, an EMR-native intelligent interface. This design avoids the common pitfall of forcing clinicians to juggle separate systems. Instead, it surfaces critical risk insights and potential next steps directly within the electronic medical record workflow they already use.

The platform continuously synthesizes a patient's full clinical history—diagnoses, labs, medications, and procedures—with the newly refined risk models. It then translates this complex analysis into clear, actionable guidance for the physician. According to one industry analyst, this integration is key to bridging the "last mile" between data science and patient outcomes. "The goal isn't to replace the clinician, but to augment them," the analyst noted. "It's about automating the routine analysis of a patient's entire history so the doctor can focus their expertise on the most critical decisions."

This network extends beyond the clinic walls. The platform includes a patient-facing application that provides personalized support and daily actions based on their care plan, integrating data from wearables and other sources. This creates a continuous feedback loop, connecting the high-level intelligence of the population-scale network to the individual's daily habits and empowering them to participate actively in their own preventive care.

The Architecture of Trust and the Israeli Model

Leveraging a national health database for AI development inevitably raises critical questions of privacy and ethics. The success of this model is built not just on technology, but on a robust "architecture of trust." The collaboration operates through Clalit’s OCEAN (Orchestration and Collaboration Environment and Network) platform, which enforces strict governance, privacy, and research approval protocols.

This framework is reinforced by Israel's strong legal and regulatory environment for data protection, including the Privacy Protection Law and the recent Medical Data Portability Law. These regulations ensure patient consent and data security are paramount, creating a trusted environment for a partnership of this scale. This combination of a unified digital health infrastructure and a strong governance framework positions Israel as a powerful global model for how to safely and effectively unlock the value of health data. It demonstrates a pathway for other nations to build intelligent health networks that can anticipate and mitigate disease on a massive scale, moving the world closer to a future defined by longer, healthier lives.